Chronic cerebral hypoperfusion accelerates Alzheimer's disease by enhancing NLRP3 inflammasome, and activating caspase-1 and IL-1β in hippocampus and thalamus of mice (Shang 2019). This evidence concerns the gene NLRP3 and early-onset autosomal dominant Alzheimer disease.